Nutriband, Inc. NTRB 深 滬
等待開盤 10-04 09:30:00 美东时间
7.43
+0.090
+1.23%
華盛通- 最 高7.45
- 今 開7.44
- 成交量 1.90万股
- 最 低 7.3065
- 昨 收 7.34
- 總市值 8862.88万
- 52周最高 11.78
- 市盈率 靜 --
- 換手率 0.16%
- 52周最低 3.7223
- 委 比 -89.55%
- 總股本 1192.85万
- 歷史最高 11.78
- 量 比 0.88
- 振 幅 1.96%
- 歷史最低 1.53
- 每 手 1
- 風險率 1.30%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Nutriband Inc. to Present at the MicroCap Rodeo Conference
Nutriband Inc. will participate in the MicroCap Rodeo Conference on Thursday, September 25, 2025, in New York City. Company Chairman Serghuei Melnik will discuss the company's operational highlights, growth initiatives, and strategic direction for its AVERSA abuse-deterrent technology. The presentation will be live at 10AM and available for virtual viewing. The conference will feature group presentations, one-on-one meetings with investors, indus...
09-24 20:05
Nutriband Q2 Adj. EPS $(0.18) Misses $(0.17) Estimate, Sales $622.452K Miss $705.000K Estimate
Nutriband (NASDAQ:NTRB) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate of $(0.17) by 5.88 percent. This is a 20 percent decrease over losses of $(0.15) per share from the same
09-10 22:05
Nutriband's six month revenue jumps 51% YY
Nutriband (NASDAQ:NTRB) produced a record six months reporting revenue of $1.29M, up 50.87% YOY, the company said on Wednesday. As of July 31, 2025, Nutriband’s cash reserves stood at $6.9 million, th...
09-10 21:34
Nutriband Reports 50.87% Revenue Growth, $6.9M Cash; Advances AVERSA Fentanyl Toward NDA With No Phase 2/3 Trials Required
Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) reported its financial results for the six months ended July 31, 2025. The company reported a strong cash position at quarter end, reinforcing its ability to advance the
09-10 21:20
Nutriband Issues Shares Amid Investor Engagement
Nutriband ( ($NTRB) ) has issued an announcement. Between February 1 and July 3...
09-04 01:28
Nutriband Inc. to Present on the Emerging Growth Conference on August 20, 2025
Nutriband Inc. has been invited to present at the Emerging Growth Conference on August 20, 2025. The live, interactive session will feature a presentation by Serguei Melnik, the Company's Chairman, followed by a Q&A session. Investors and analysts can submit questions in advance or ask them during the event. Nutriband Inc. will present at 9:40 AM Eastern time for 30 minutes. Registration is required to attend, and an archived webcast will be avai...
08-18 13:00
Nutriband CEO Gareth Sheridan Steps Aside To Run For Irish Presidency, Chairman Serguei Melnik Takes Helm Ahead Of FDA Milestone
Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) has announced that Company CEO, Gareth Sheridan will be stepping aside from his role for three months to enter the Irish Presidential election. The Nomination Hearings followed
08-11 17:07
Nutriband CEO Gareth Sheridan Seeks Nomination in Upcoming Irish Presidential Election
Gareth Sheridan, CEO of Nutriband Inc., will temporarily step aside from his role for three months to run in the Irish Presidential election. During this period, Serguei Melnik, Co-Founder and Chairman, will serve as interim CEO, guiding the company toward its 2026 NDA filing target for AVERSA Fentanyl, an abuse-deterrent opioid patch. The FDA has granted Nutriband a meeting request for AVERSA Fentanyl, which aims to address the global need for e...
08-11 09:00
Nutriband Completes Stock Dividend of Preferred Shares
An update from Nutriband ( ($NTRB) ) is now available. On July 9, 2025, Nutriba...
08-08 06:15
Nutriband To Issue 25% Preferred Stock Dividend To Shareholders Of Record On July 25, Convertible Upon FDA Approval Of AVERSA Fentanyl
Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) ("Nutriband" or the "Company") is today reminding shareholders of the key dates associated with its upcoming 25% Preferred stock dividend.Shareholders of record on July
07-18 21:37
